Combination therapy in the integrated treatment of recurrent chronic cystitis

Cover Page
Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract


Aim. To assess the results of the integrated treatment of women with recurrent chronic cystitis using the selective β3-adrenoreceptor (AR) agonist, mirabegron.

Methods. The results of the treatment of women diagnosed with recurrent chronic cystitis in the urological cli­nic of KSMU were analyzed. The average age of patients was 31.5±3.4 years. To assess the effectiveness of integra­ted treatment, women with recurrent chronic cystitis were randomly divided into two groups: the first group (30 patients) who received antibiotic therapy in combination with the drug mirabegron at a dose of 50 mg once a day and the second (control) group (30 patients), who received antibiotic therapy taking into account their susceptibility. All patients underwent ultrasonography of the genitourinary system, urodynamic studies with assessment of the ma­ximum urinary flow, average urinary flow, bacterial urine cultures.

Results. Analysis of the research results showed a greater reduction in the number of urinations per day (up to 7 times) in the first group. The frequency of urinary urgency decreased in 82.6% of the first group patients compared to 64% of the second group (p <0.05). In the combination therapy versus control groups, there was reduced hospital stay by an average of 4 days (11.2 vs 15 days; p <0.05). On the 15th day of treatment, control cystoscopy revealed no changes in the bladder mucosa in all patients of the first group. Also, in the first group of patients, there was a greater improvement in urodynamic parameters compared to the control group (p <0.05).

Conclusion. The selective β3-AR agonist mirabegron used in the integrated treatment of recurrent chronic cystitis increases the effectiveness of the therapy.


Full Text

Restricted Access

About the authors

D R Sayapova

Kazan State Medical University

Author for correspondence.
Email: sayapova.69@mail.ru

Russian Federation, Kazan, Russia

A Yu Zubkov

Kazan State Medical University

Email: sayapova.69@mail.ru

Russian Federation, Kazan, Russia

References

  1. Abrams P., Cardozo J., Fall M. The stadartisation of terminology of lower urinary tract function. Neurourol. and Urodyn. 2002; 21; 167–168. doi: 10.1002/nau.10052.
  2. Gadzhieva Zh.K. Narusheniya mocheispuskaniya. (Urination disorders.) Pod red. Yu.G. Alyaeva. M.: GEOTAR-­Media. 2010; 176 р. (In Russ.)
  3. Urologiya. Rossiyskie klinicheskie rekomendatsii. (Urology. Russian clinical guidelines.) Ed. by Yu.G. Alyaeva, P.V. Glybochko, D.Yu. Pushkarya. M.: GEOTAR-Media. 2015; 480 р. (In Russ.)
  4. Gyaurgiev T.A., Kuzmenko A.V., Vachtel V.M., Lukyanovich P.A. Treatment of patients with chronic recurrent bacterial cystitis in the acute stage in combination with phototherapy using the apparatus “Svetozar”. Sistemnyy analiz i upravlenie biome­ditsinskikh sistemakh. 2014; 13 (4): 821–824. (In Russ.)
  5. Glybochko P.V., Alyaev Yu.G., Gadzhieva Z.G. et al. The use of hyaluronic acid in the treatment of chronic cystitis. Ehffektivnaya farmakotera­piya. 2011; (45): 8–11. (In Russ.)
  6. Faxman B. Epidemilogy of urinary tract infections: incidence, morbidity, and economic costs. Dis. Mon. 2003; 9 (1): 53–70. doi: 10.1067/mda.2003.7.
  7. Sinyakova L.A. Contemporary views on antibiotic therapy of the urinary tract. Management tactics for patients with recurrent cystitis. Urologiya. 2010; (3): 45–49. (In Russ.)
  8. Neimark B.A. Treatment of persistent dysuria in females. Urologiya. 2003; (3): 16–20. (In Russ.)
  9. Damiano R., Cicione A. The role of sodium hyaluronate and sodium chondroitin sulphate in the management of bladder disease. Adv. Urol. 2011; 3 (5): 223–232. doi: 10.1177/1756287211418723.
  10. Geppetti P., Nassini R., Materazzi S., Benemli S. The concept of neurogenic inflammation. BJU Jnt. 2008; 101 (suppl. 3): 2–6. doi: 10.1111/j.1464-410X.2008.07493.x.
  11. Tyagi P., Barclay D., Zamora R. et al. Urine cytokines suggest an inflammatory response in the overactive bladder a pilot study. Jnt. Urol. Nephrol. 2010; 42 (3): 629–635. doi: 10.1007/s11255-009-9647-5.

Supplementary files

Supplementary Files Action
1.
Рис. 1. Частота мочеиспусканий по данным дневников мочеиспусканий

Download (16KB) Indexing metadata
2.
Рис. 2. Количество ургентных позывов по данным дневников мочеиспускания

Download (16KB) Indexing metadata

Statistics

Views

Abstract - 88

PDF (Russian) - 1

Cited-By


PlumX

Dimensions


© 2020 Sayapova D.R., Zubkov A.Y.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies